PT Pyridam Farma Tbk - Income Statement (TTM)

PT Pyridam Farma Tbk
ID ˙ IDX
Income Statement (TTM)

PT Pyridam Farma Tbk Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 257,674 277,398 315,777 378,335 488,496 630,530 685,557 715,132 775,078 715,425 707,846 721,928 684,977 702,068 688,841 795,774 1,343,422 1,920,812 2,454,633 2,898,895
Change (%) 7.65 13.84 19.81 29.12 29.08 8.73 4.31 8.38 -7.70 -1.06 1.99 -5.12 2.50 -1.88 15.52 68.82 42.98 27.79 18.10
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 104,700 113,508 135,704 175,501 242,657 385,949 428,550 455,346 546,383 464,580 461,452 465,389 394,551 407,050 408,139 490,898 975,878 1,394,225 1,806,868 2,224,520
Change (%) 8.41 19.55 29.33 38.27 59.05 11.04 6.25 19.99 -14.97 -0.67 0.85 -15.22 3.17 0.27 20.28 98.79 42.87 29.60 23.11
% of Revenue 40.63 40.92 42.97 46.39 49.67 61.21 62.51 63.67 70.49 64.94 65.19 64.46 57.60 57.98 59.25 61.69 72.64 72.59 73.61 76.74
Gross Operating Profit 152,974 163,890 180,073 202,834 245,839 244,581 257,007 259,786 228,695 250,845 246,393 256,539 290,427 295,017 280,702 304,877 367,544 526,587 647,765 674,375
Change (%) 7.14 9.87 12.64 21.20 -0.51 5.08 1.08 -11.97 9.69 -1.77 4.12 13.21 1.58 -4.85 8.61 20.55 43.27 23.01 4.11
% of Revenue 59.37 59.08 57.03 53.61 50.33 38.79 37.49 36.33 29.51 35.06 34.81 35.54 42.40 42.02 40.75 38.31 27.36 27.41 26.39 23.26
SG&A 140,348 134,340 133,448 147,743 175,207 219,977 235,143 245,819 287,735 286,433 294,282 313,600 283,380 302,848 319,998 353,719 412,155 542,922 647,021 709,229
Change (%) -4.28 -0.66 10.71 18.59 25.55 6.89 4.54 17.05 -0.45 2.74 6.56 -9.64 6.87 5.66 10.54 16.52 31.73 19.17 9.61
% of Revenue 54.47 48.43 42.26 39.05 35.87 34.89 34.30 34.37 37.12 40.04 41.57 43.44 41.37 43.14 46.45 44.45 30.68 28.27 26.36 24.47
R&D 573 -573
Change (%)
% of Revenue 0.12 -0.07
OpEx 229,633 245,997 267,666 322,242 430,317 579,418 639,873 652,840 426,491 725,410 720,665 771,966 1,025,261 700,267 716,156 850,383 1,470,170 1,921,570 2,444,509 2,915,920
Change (%) 7.13 8.81 20.39 33.54 34.65 10.43 2.03 -34.67 70.09 -0.65 7.12 32.81 -31.70 2.27 18.74 72.88 30.70 27.21 19.28
% of Revenue 89.12 88.68 84.76 85.17 88.09 91.89 93.34 91.29 55.03 101.40 101.81 106.93 149.68 99.74 103.97 106.86 109.43 100.04 99.59 100.59
Operating Income 28,042 31,401 48,110 56,093 58,179 51,113 45,684 62,292 348,588 -9,985 -12,820 -50,038 -340,283 1,801 -27,315 -54,609 -126,748 -758 10,124 -17,025
Change (%) 11.98 53.21 16.59 3.72 -12.15 -10.62 36.35 459.60 -102.86 28.39 290.32 580.05 -100.53 -1,616.65 99.92 132.10 -99.40 -1,434.88 -268.17
% of Revenue 10.88 11.32 15.24 14.83 11.91 8.11 6.66 8.71 44.97 -1.40 -1.81 -6.93 -49.68 0.26 -3.97 -6.86 -9.43 -0.04 0.41 -0.59
Interest Expense -1,950 -2,146 -10,599 -19,260 -28,598 -41,927 -47,767 -60,387 -79,576 -86,911 -93,109 -92,452 -85,283 -85,795 -91,090 -103,954 -163,752 -212,198 -257,203 -301,907
Change (%) 10.04 393.93 81.71 48.49 46.61 13.93 26.42 31.78 9.22 7.13 -0.71 -7.75 0.60 6.17 14.12 57.52 29.59 21.21 17.38
% of Revenue -0.76 -0.77 -3.36 -5.09 -5.85 -6.65 -6.97 -8.44 -10.27 -12.15 -13.15 -12.81 -12.45 -12.22 -13.22 -13.06 -12.19 -11.05 -10.48 -10.41
Net Income 20,539 22,104 28,590 27,773 21,948 5,479 -2,877 3,165 278,272 275,241 260,664 229,504 -66,728 -85,221 -116,016 -140,158 -244,022 -330,247 -377,733 -451,826
Change (%) 7.62 29.34 -2.86 -20.97 -75.04 -152.51 -210.00 8,692.22 -1.09 -5.30 -11.95 -129.07 27.71 36.14 20.81 74.11 35.33 14.38 19.62
% of Revenue 7.97 7.97 9.05 7.34 4.49 0.87 -0.42 0.44 35.90 38.47 36.82 31.79 -9.74 -12.14 -16.84 -17.61 -18.16 -17.19 -15.39 -15.59

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista